Get started
Author

Karin Wilhelm-Ogunbiyi

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
2008 · Werner Hacke, Anthony J Furlan, et al. · The Lancet Neurology · 578
A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy
2014 · Keith M. Borkett, Dennis S. Riff, et al. · Anesthesia & Analgesia · 232
A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy
2013 · Mark T. Worthington, Laurie J. Antonik, et al. · Anesthesia & Analgesia · 183
A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy
2015 · Daniel J. Pambianco, Keith M. Borkett, et al. · Gastrointestinal Endoscopy · 175
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
2004 · P. Schöffski, S. Riggert, et al. · Annals of Oncology · 83
Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue
2010 · Thijs van Iersel, Heimo Stroissnig, et al. · Thrombosis and Haemostasis · 27
Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours
2005 · P. Schöffski, I. Breidenbach, et al. · European Journal of Cancer · 26
Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)
2008 · Lothar Bergmann, Steiner Aamdal, et al. · European Journal of Cancer · 22
Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples
2005 · Michael Adler, Martin Langer, et al. · Journal of Pharmaceutical and Biomedical Analysis · 15
A Phase IIA, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy
2015 · Keith M. Borkett, Dennis S. Riff, et al. · Survey of Anesthesiology · 10
Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lung.
2005 · Katharina Blonski, Udo Schumacher, et al. · PubMed · 6
rViscumin, a novel anticancer agent — preclinical and clinical development status
2001 · K. Wilhelm-Ogunbiyi, B. Möckel, et al. · European Journal of Cancer · 2
Assessing the cancerostatic potency of rViscumin towards human tumor xenografts and cell lines in vitro
2001 · B. Möckel, A. Burger, et al. · European Journal of Cancer · 2
A Phase IIb Study Comparing the Safety and Efficacy of Remimazolam and Midazolam in Colonoscopy Patients
2014 · Daniel Pambianco, Keith Borkett, et al. · The American Journal of Gastroenterology · 1
A Phase 1B Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy
2014 · Mark T. Worthington, Laurie J. Antonik, et al. · Survey of Anesthesiology · 1
S1419: A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy
2010 · Dennis S. Riff, Peter J. Winkle, et al. · Gastrointestinal Endoscopy
S1399: A Phase IB Study of the Safety and Efficacy of Multiple Doses of CNS 7056 in Volunteers Undergoing Colonoscopy, Including Reversal With Flumazenil
2010 · Mark T. Worthington, Laurie Antonik, et al. · Gastrointestinal Endoscopy
209 Phase I clinical trial in patients with refractory solid tumors: the weekly 24 hour intravenous infusion of aviscumine, a recombinant ribosome-inactivating protein
2004 · P. Schöffski, I. Breidenbach, et al. · European Journal of Cancer Supplements
Phase I evaluation of the weekly 24 hour intravenous administration of aviscumine, a recombinant ribosome-inactivating protein, in patients with refractory solid tumors
2004 · P. Schöffski, I. Breidenbach, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 1,363
H-index: 10
I10-index: 10
Year
Topic
Type